Sana Biotechnology Reports Quarterly Results for Quarter Ended June 30, 2026

What Happened
Sana Biotechnology, Inc. filed a Form 8-K on August 10, 2026 to announce its financial results for the quarter ended June 30, 2026. The company issued a press release with the quarterly results, which is attached to the 8-K as Exhibit 99.1. The filing also includes the Cover Page Interactive Data File (iXBRL) as Exhibit 104.

Key Details

• Filing date: August 10, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Reporting period: quarter ended June 30, 2026.
• Press release with the financial results is attached as Exhibit 99.1.
• Interactive XBRL cover page included as Exhibit 104.

Why It Matters
This 8-K is the company’s official disclosure that the quarter’s financial results have been released; investors should read the attached press release for specifics such as revenue, net income/loss, R&D spending, cash position and any guidance or operational updates. Those figures and any commentary in the release can affect Sana’s near-term stock performance and inform decisions about the company’s financial health and runway.